Guggenheim Capital’s Intercept Pharmaceuticals, Inc. ICPT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q4
Sell
-22,285
Closed -$413K 1995
2023
Q3
$413K Buy
+22,285
New +$252K ﹤0.01% 1514
2020
Q4
Sell
-35,357
Closed -$1.47M 2131
2020
Q3
$1.47M Buy
35,357
+1,408
+4% +$64.7K 0.01% 1031
2020
Q2
$1.63M Buy
33,949
+11,016
+48% +$851K 0.01% 971
2020
Q1
$1.44M Sell
22,933
-5,044
-18% -$453K 0.01% 928
2019
Q4
$3.47M Sell
27,977
-2,785
-9% -$249K 0.03% 799
2019
Q3
$2.04M Sell
30,762
-167
-0.5% -$11.2K 0.02% 1004
2019
Q2
$2.46M Buy
30,929
+2,379
+8% +$213K 0.02% 962
2019
Q1
$3.19M Buy
28,550
+787
+3% +$86K 0.03% 861
2018
Q4
$2.8M Sell
27,763
-2,383
-8% -$247K 0.02% 871
2018
Q3
$3.81M Sell
30,146
-6,181
-17% -$654K 0.02% 874
2018
Q2
$3.05M Buy
36,327
+23,766
+189% +$1.74M 0.02% 1009
2018
Q1
$772K Sell
12,561
-24,350
-66% -$1.47M ﹤0.01% 2199
2017
Q4
$2.16M Sell
36,911
-9,280
-20% -$585K 0.01% 1615
2017
Q3
$2.68M Buy
46,191
+16,960
+58% +$1.83M 0.01% 1458
2017
Q2
$3.54M Buy
29,231
+1,340
+5% +$155K 0.01% 1219
2017
Q1
$3.15M Sell
27,891
-10
-0% -$1.17K 0.01% 1310
2016
Q4
$3.03M Sell
27,901
-25
-0.1% -$2.98K 0.01% 1351
2016
Q3
$4.6M Sell
27,926
-1,210
-4% -$191K 0.01% 1059
2016
Q2
$4.16M Sell
29,136
-2,580
-8% -$376K 0.01% 1093
2016
Q1
$4.08M Sell
31,716
-9,108
-22% -$1.08M 0.01% 1099
2015
Q4
$6.1M Sell
40,824
-16,832
-29% -$2.85M 0.02% 932
2015
Q3
$9.56M Buy
57,656
+4,629
+9% +$1.02M 0.03% 770
2015
Q2
$12.8M Buy
53,027
+11,841
+29% +$3.15M 0.03% 744
2015
Q1
$11.6M Sell
41,186
-9,596
-19% -$2.08M 0.03% 797
2014
Q4
$7.92M Buy
50,782
+21,272
+72% +$3.93M 0.02% 928
2014
Q3
$6.99M Buy
29,510
+2,647
+10% +$675K 0.02% 1047
2014
Q2
$6.36M Buy
26,863
+1,451
+6% +$382K 0.02% 1056
2014
Q1
$8.38M Sell
25,412
-30,302
-54% -$10.2M 0.02% 911
2013
Q4
$3.8M Buy
+55,714
New +$3.22M 0.01% 1259